| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/06/2008 | US20080058246 Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof with preserved receptor-binding activity |
| 03/06/2008 | US20080057593 Method for the prediction, diagnosis and differential diagnosis of Alzheimer's disease |
| 03/06/2008 | US20080057579 Methods and products for manipulating hematopoietic stem cells |
| 03/06/2008 | US20080057565 Method for overexpression of zwitterionic polysaccharides |
| 03/06/2008 | US20080057524 Neurotransmission disorders |
| 03/06/2008 | US20080057520 Immunoassays for specific determination of scca isoforms |
| 03/06/2008 | US20080057519 Monoclonal antibody specific for b-cell chronic lymphocytic leukemia cell surface protein; diagnosing cell proliferative disorders of blood |
| 03/06/2008 | US20080057515 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 03/06/2008 | US20080057504 Nucleotide sequences comprising mutation in untranslated coding region of ATP-gated ion channel (P2X7R) for use as tool in diagnosing psychological disorders |
| 03/06/2008 | US20080057495 Marchantiales-Derived Unsaturated Fatty Acid Synthetase Genes And Use Of The Same |
| 03/06/2008 | US20080057080 Polynucleotide comprising a first nucleic acid fragment which encodes at least 20 contiguous amino acids of an influenza virus polypeptide, wherein codons of nucleic acid fragment are optimized for expression in humans; enhancing immune response of vertebrate in need of protection against IV infection |
| 03/06/2008 | US20080057077 Tumour-associated peptides binding to mhc-molecules |
| 03/06/2008 | US20080057070 Antagonist Anti-Cd40 Monoclonal Antibodies and Methods for Their Use |
| 03/06/2008 | US20080057069 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue |
| 03/06/2008 | US20080057067 Immunogenic polypeptide fragments and vaccines; outer membrane proteins; prevention of infections including meningitis |
| 03/06/2008 | US20080057066 Methods and compositions for targeting relt |
| 03/06/2008 | US20080057065 Phep, an Amino Acid Permease of Staphylococcus Aureus |
| 03/06/2008 | US20080057064 Erbb3 Based Methods and Compositions for Treating Neoplasms |
| 03/06/2008 | US20080057063 human monoclonal antibodies; diagnostics and treatment of diseases associated with the activity and/or overproduction of alpha V beta 6; cancer |
| 03/06/2008 | US20080057060 Method and system to remove cytokine inhibitor in patients |
| 03/06/2008 | US20080057058 Uses of il-23 agonists and antagonists; related reagents |
| 03/06/2008 | US20080057057 Anti-Lipid Rafts Antibodies |
| 03/06/2008 | US20080057056 Fc Variants with Increased Affinity for FcyRIIC |
| 03/06/2008 | US20080057033 Neural Stem Cells and Methods of Generating and Utilizing Same |
| 03/06/2008 | US20080056997 preferential binding members against extracellular matrix proteins, especially scFv antibody molecules against peptide domains of the glycoprostien, conjugated with labels, cytotoxic molecules or cytokines, for use in diagnosis and treatment of cancer |
| 03/06/2008 | CA2661875A1 Combination hepatitis c virus antigen and antibody detection method |
| 03/06/2008 | CA2661848A1 Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals |
| 03/06/2008 | CA2661803A1 Antibodies, assays and hybridomas |
| 03/06/2008 | CA2661782A1 Antagonistic human light-specific human monoclonal antibodies |
| 03/06/2008 | CA2660175A1 Variable region sequences of il-31 monoclonal antibodies and methods of use |
| 03/05/2008 | EP1895017A2 Use of A33 antigens and JAM-IT |
| 03/05/2008 | EP1895006A1 Interleukin-17 related mammalian cytokines. Polynucleotides encoding them. Uses |
| 03/05/2008 | EP1895005A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 03/05/2008 | EP1895004A1 Human hippocalcin gene variant associated with cancers |
| 03/05/2008 | EP1895002A1 Novel trypsin family serine proteases |
| 03/05/2008 | EP1895001A1 Novel trypsin family serine proteases |
| 03/05/2008 | EP1894002A1 Receptor in dendritic cells |
| 03/05/2008 | EP1893741A1 Cell-based microarrays, and methods for their preparation and use |
| 03/05/2008 | EP1893649A2 Method for the potentiation of opioid analgesics effects on pain |
| 03/05/2008 | EP1893648A2 Antibodies against bacterial antigens and their use in the generation of immune response against apoptotic cells |
| 03/05/2008 | EP1893647A2 Antibody formulations having optimized aggregation and fragmentation profiles |
| 03/05/2008 | EP1893646A2 Methods and compositions for targeting ifnar2 |
| 03/05/2008 | EP1893645A1 Optimization of west nile virus antibodies |
| 03/05/2008 | EP1893234A2 MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT |
| 03/05/2008 | EP1893228A2 Chimericpoly peptides and the therapeutic use thereof against a flaviviridae infection |
| 03/05/2008 | EP1718967A4 METHODS OF DETECTING Lp-PLA2 ACTIVITY |
| 03/05/2008 | EP1670912B1 Method for linking sequences of interest |
| 03/05/2008 | EP1583504A4 Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
| 03/05/2008 | EP1558086A4 Cell targeting methods and compositions |
| 03/05/2008 | EP1238985B1 Human type complementarity determining region transplantation antibody against ganglioside gd3 and derivatives of antibody against ganglioside gd3 |
| 03/05/2008 | EP1214418B1 Nucleic acid which is obtained from tetrahymena and which codes for a delta-6-desaturase, the production thereof and use |
| 03/05/2008 | EP1207904B1 New clinical parameters for determining hematologic toxicity prior to radioimmunotherapy |
| 03/05/2008 | EP1064360B1 Luciferases, gfp fluorescent proteins, their nucleic acids and the use thereof in diagnostics |
| 03/05/2008 | EP1030862B1 Viral clearance process |
| 03/05/2008 | EP0960337B1 Cathepsin K and breast cancer |
| 03/05/2008 | CN101137673A Cripto结合分子 Cripto binding molecules |
| 03/05/2008 | CN101137672A Diagnosis of prostate cancer |
| 03/05/2008 | CN101137671A Anti-igsf4 antibody and utilization of the same |
| 03/05/2008 | CN101137670A Method for the in vitro diagnosis of alzheimer's disease using a monoclonal antibody |
| 03/05/2008 | CN101137664A Antigenic epitopes of interleukin-21, related antibodies and their use in medical field |
| 03/05/2008 | CN101134779A Antibodies specific for human CD22 and their therapeutic and diagnostic uses |
| 03/05/2008 | CN101134778A Monoclonal antibody of esophagus cancer resistant blood vessel endothelium cell |
| 03/05/2008 | CN101134777A Method for preparing humanized immune globulin capable of antagonizing vessel endothelium cell growth factor and combined uses thereof |
| 03/05/2008 | CN101134772A Method for separating membrane protein of sucking sperm rear head and uses thereof |
| 03/05/2008 | CN101134107A Antithrombotic agents |
| 03/05/2008 | CN100372944C The use of PDE4D in the screening for medicaments against atherosclerosis |
| 03/05/2008 | CN100372938C Gene encoding labyrinthin, a marker for cancer |
| 03/04/2008 | US7339051 Compositions and methods for the treatment of severe acute respiratory syndrome (SARS) |
| 03/04/2008 | US7339047 Comprises nucleotide sequences coding interleukin-1b converting enzyme ligand for use in diagnosis, prevention and treatment of autoimmune, connective tissue and crohn's diseases |
| 03/04/2008 | US7339039 Nucleic acids encoding receptor recognition factors, and methods of use thereof |
| 03/04/2008 | US7339038 Heparanase specific molecular probes and their use in research and medical applications |
| 03/04/2008 | US7339035 Antibody recognizing GM1 ganglioside-bound amyloid β-protein and DNA encoding the antibody |
| 03/04/2008 | US7339034 For release of tumor necrosis and or cellular differentation/proliferation of chrondrocytes by contacting blood w/polypeptides; cancer diagnosis |
| 03/04/2008 | US7339033 Pro1481 |
| 03/04/2008 | US7339031 Cancer therapeutics; inhibits protein synthesis on ribosomes |
| 03/04/2008 | US7339030 Human semaphorin L (H-SemaL) and corresponding semaphorins in other species |
| 03/04/2008 | US7339029 Sperm-specific cation channel, CatSper2, and uses therefor |
| 03/04/2008 | US7339022 Histological certification of lymphatic vessels and the immunohistochemical inspection for malignant invasion into the lymphatic vessels; an epitope of a lymphatic vessel-specific antibody; immunostaining |
| 03/04/2008 | US7338929 Cancer immunotherapy |
| 03/04/2008 | US7338797 Compositions for isolating a cDNA encoding a membrane-bound protein |
| 03/04/2008 | US7338774 Method for determining activity of cell cycle regulatory factor and method for diagnosing cancer using the same |
| 03/04/2008 | US7338772 RF-amide peptides and their use for treating, preventing and curing neurological and metabolic medical disorders. The invention also relates to methods for modulating a G-protein coupled receptor and for identifying substances which modulate |
| 03/04/2008 | US7338770 Using calcitonin precursor protein as diagnostic tool in detection of cancer and sepsis |
| 03/04/2008 | US7338660 Methods of treating cancer and enhancing immune responses with antibodies that bind CD40 |
| 03/04/2008 | US7338659 Reducing immunogenicities of immunoglobulins by framework-patching |
| 03/04/2008 | US7338658 Chimeric antibody specific to human CD4 which comprises the variable heavy and light chain sequences of an Old World monkey monoclonal antibody produced against human CD4 and human constant heavy and light domain sequences |
| 02/28/2008 | WO2008023771A1 Culture vessel, and gene introduction method and cell culture method using the vessel |
| 02/28/2008 | WO2008023689A1 Method of producing fused protein |
| 02/28/2008 | WO2008022963A2 Isolation and characterization of a novel pythium omega 3 desaturase with specificity to all omega 6 fatty acids longer than 18 carbon chains |
| 02/28/2008 | WO2008022746A1 Tumor therapy with an anti-vegf antibody |
| 02/28/2008 | WO2008022401A1 Recombinant hcv e2 glycoprotein |
| 02/28/2008 | WO2008022391A1 Method for producing antibodies |
| 02/28/2008 | WO2008022390A1 Anti-c5ar antibodies with improved properties |
| 02/28/2008 | WO2008006235A3 Scfv antibodies which pass epithelial and/or endothelial layers |
| 02/28/2008 | WO2007147623A3 A novel target in the treatment of cytokine release syndrome |
| 02/28/2008 | WO2007145862A3 Extending survival of cancer patients with elevated levels of egf or tgf-alpha |
| 02/28/2008 | WO2007127221A3 Targeted delivery to leukocytes using non-protein carriers |
| 02/28/2008 | WO2007110678A3 Neutralizing antibodies and methods of use thereof |
| 02/28/2008 | WO2007110205A3 Engineered heterodimeric protein domains |
| 02/28/2008 | WO2007094842A3 Binding polypeptides and uses thereof |